Vetter Awarded For Its Innovative Strength

Vetter Pharma-Fertigung GmbH & Co. KG, world leader in the production of aseptically prefilled injection systems, has won this year's "Facility of the Year Award" in the "Process Innovation" category for its new facility Ravensburg Vetter South (RVS). The award, which is sponsored jointly by ISPE, INTERPHEX, and the magazine Pharmaceutical Processing, is one of the most important distinctions in the pharmaceutical industry. An international jury of experts selected RVS for its technological innovations which are optimally designed to meet the existing and future demands of the pharmaceutical manufacturing of prefilled syringes, cartridges and vials.

"The facility," according to the jury, "is the result of more than a quarter of a century of expertise in aseptically pre-filling. It features maximum automation, high standards of sterility, safety and quality." They noted in particular that "automation was planned throughout the building, from door openers to the use of the brand new Restricted Access Barrier System (RABS) on the filling lines." With the facility, which began operating in October 2006, the company will increase its capacity to 400 million units per year. The company's production site currently has two filling lines for liquid and lyophilized drugs in the following systems: dual-chamber syringes, single- and dual-chamber cartridges and vials. Two more lines will be added in the near future.

About Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG has been active as an independent pharmaceutical service partner for over 50 years. 25 years ago, Vetter began focusing on the fill & finish of liquid and lyophilized drugs. In addition to standard injection systems and cartridges, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. This 1,800-strong company has 20 years of experience in working with clients products and processes approved by the FDA, the EMEA and other authorities. Vetter currently has more than 127 patents to its name, including solutions to prevent counterfeiting and piracy. The company acts as a strategic partner for biotech and pharmaceutical companies. Vetter Development Service works with your product from its clinical development through its market launch. Vetter Commercial Manufacturing handles the entire process, from compounds and aseptic filling to the final packaging of the product. Vetter Solutions patented application systems excel in the marketplace thanks to their high quality, efficient production processes and patient-friendly designs. This know-how, made available to Vetter partners through Vetter's production capabilities, offers a competitive edge in markets throughout the world.

Source: Vetter Pharma-Fertigung GmbH & Co. KG